[皮下除器 (S-ICD) ]是指皮下除器
Jürgen Kuschyk1,2, Fabian Fastenrath3, Katherine Sattler3
1I. Medizinische Klinik, Sektion für Invasive Kardiologie und Elektrophysiologie, Universitätsmedizin Mannheim, Mannheim, Deutschland. juergen.kuschyk@umm.de.
Herz
|October 7, 2025
概括
皮下植入式心脏转换器除器 (S-ICD) 提供有效的预防突然心脏死亡,其冲击转换率为98%. 与静脉输入性ICD相比,它显著减少了与有关的并发症,使其成为一种安全的替代品.
科学领域:
- 心脏病学 心脏病学
- 医疗器械 医疗器械
- 电子生理学 电子生理学
背景情况:
- 突然心脏死亡 (SCD) 需要按照既定指南进行有效的除器治疗.
- 透静脉植入式心脏转换器-除器 (TV-ICDs) 携带与有关的并发症和感染的风险.
- 皮下植入式心脏转换器-除器 (S-ICD) 提供了一个没有心脏内导线的替代方法.
研究的目的:
- 评估S-ICD系统的有效性和安全性.
- 将S-ICD结果与传统的TV-ICD结果进行比较.
- 建立S-ICD作为特定患者群体的常规临床选择.
主要方法:
- 从随机试验和注册表中分析了来自5000名参与者的数据.
- 对包括PRAETORIAN,UNTOUCHED,EFFORTLESS,PAS和ATLAS在内的里程碑性研究的审查.
- 评估标准化的S-ICD植入技术和编程策略.
主要成果:
- S-ICD显示了大约98%的冲击转换效率.
- 与TV-ICD相比,S-ICD显示严重和相关并发症的发生率明显较低.
- 研究证实了S-ICD在现实临床环境中的安全性和有效性.
结论:
- S-ICD是电视-ICD的安全和有效替代品,特别是对于不需要节奏的患者.
- 建议S-ICD用于年轻患者,感染风险较高,静脉通道有限或遗传性心律失常综合征患者.
- 优化的植入和编程可以提高S-ICD的性能和患者的治疗结果.
相关概念视频
Cardiopulmonary Resuscitation III: AED Use
530
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
530
Cardiomyopathy V: Interprofessional Care
338
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
338
Dysrhythmias VI: Management of Dysrhythmias
431
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
431
Cardiopulmonary Resuscitation IV: Pharmacological Management
655
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
655
Cardiopulmonary Resuscitation I: Adult
580
Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
580
Heart Failure VI: Adjunct Therapies
255
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
255


